JPMORGAN CHASE & CO - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is and the CUSIP is 78667J908. A total of 5 filers reported holding SAGE THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$1,346,000
-83.7%
23,700
-78.5%
0.00%
-100.0%
Q1 2021$8,241,000
+115.5%
110,100
+149.1%
0.00%0.0%
Q4 2020$3,824,000
+153.2%
44,200
+74.7%
0.00%
Q3 2020$1,510,000
+3495.2%
25,300
+2430.0%
0.00%
Q2 2020$42,000
-99.5%
1,000
-99.1%
0.00%
-100.0%
Q4 2019$8,316,000
+29600.0%
115,200
+57500.0%
0.00%
Q3 2019$28,000
-22.2%
2000.0%0.00%
Q2 2019$36,000
-99.9%
200
-99.9%
0.00%
-100.0%
Q1 2019$53,282,000
+4115.3%
335,000
+1566.7%
0.01%
Q3 2017$1,264,00020,1000.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
BOOTHBAY FUND MANAGEMENT, LLC 76$657,0000.02%
GROUP ONE TRADING, L.P. 66,700$5,770,0000.01%
SIMPLEX TRADING, LLC 275$2,379,0000.00%
IMC-Chicago, LLC 15,200$1,315,0000.00%
JPMORGAN CHASE & CO 44,200$3,824,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SAGE THERAPEUTICS INC shareholders